Luna Becomes the Fasting Growing PT Clinic Nationally, & Earns “Exceptional” Award from Medicare

Luna has become the fastest growing physical therapy (PT) clinic nationally[1] with 6,183% growth in visits during the four consecutive years since it was founded in 2018. This is higher than any reported growth during the same time frame from any PT clinic group.

Luna’s outpatient “rehab-at-home” model is shaking up healthcare and, to date, has treated over 25,000 patients. Delivering high quality in-person PT care to a patient’s home, Luna now operates across 45 markets in 25 states, with one of its thousands of licensed physical therapists visiting a patient’s home every 45 seconds.

Luna has earned the trust of countless patients, therapists, physicians, and partners, culminating in its recent designation as an “Exceptional” provider by the Medicare/CMS, the highest level of achievement possible in this category. This award by the Merit-based Incentive Payment System (MIPS) demonstrates Luna’s commitment to exceptional care and in particular enabling outcomes via significant pain and functional improvements for patients with lower back, knee, neck, and ankle conditions.

Health Systems and Orthopaedic Groups are Embracing Luna

Luna’s rapid growth is driven by partnerships with over 50 health systems and orthopaedic groups, including Emory Health, Intermountain Healthcare and UCLA Health, to address the $2.5 billion loss in annual revenue for health systems, given that 55% of PT patients referred to a health system clinic seek care outside the system.

“People will drive a long way to have surgery, but not a couple times a week to have rehab,” said Dr. Scott Boden, Director of the Emory Orthopaedics & Spine Center and Vice President for Business Innovation for Emory Healthcare. “Luna allows us to extend access to care to all patients across our metropolitan area, who otherwise might have been at a higher risk of failure because they didn’t have the right PT.”

Cost Effective Solution for At-Risk Providers

Luna recently demonstrated how its outpatient in-home PT saves an average of $3,000 per case for post-surgical rehab for bundled care cases, equating to Medicare savings of 55%-70% per case.

“Luna is the future of healthcare,” said Mike West, former CEO of Rothman Orthopaedic Institute. “90% of patients choose in-person delivery vs. a clinic when offered both choices. With Luna, health systems, surgeons, and orthopedic groups can ensure patients receive convenient, high quality care from their home.”

Unique Technology Platform and Network of Therapists

Using the Luna technology platform, physical therapists can optimize delivery of care via scheduling, matching, and routing – as well as incorporating charting, insurance claims, and documentation in a streamlined manner. Luna has introduced many innovations in its platform, including Auto-Charting®, Safety Shield®, Luna Protocols and Care Pathways, Luna Dashboards for physicians, and integrated Luna Exercises.

Unlike virtual-only or digital-only PT providers, Luna’s technology-first approach and network of exceptional and licensed therapists deliver the best of both worlds. This ensures physical therapists have access to specific protocols and care pathways to patients – and can track progress in real-time.

“Post-pandemic, consumers and providers are increasingly looking for ways to safely access and deliver rehab at home – and that’s what excites us about the future of healthcare,” says Palak Shah, Luna co-founder and head of clinical operations. “Our team of therapists and tech innovations makes us perfectly placed to deliver safe, high quality PT care in the patient’s home while providing critical relief for health systems.”

[1] Luna experienced growth of 6,183% in visits from 2018 to 2022, with >100% growth per annum for each of the four years.

SourceLuna

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”